Finance

Beta
Lists
VYGR:NASDAQ
Voyager Therapeutics Inc
$3.33
-8.01%
(-0.29) 1D
$3.50
+5.11% (+0.17)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VYGR...
Open
$3.61
High
$3.61
Low
$3.32
Mkt. cap
201.20M
Avg. vol.
532.92K
Volume
650.90K
52-wk high
$5.55
52-wk low
$2.83
EPS
-$1.98
Beta
1.25
Shares outstanding
60.42M
No. of employees
141
Open
$3.61
High
$3.61
Low
$3.32
Mkt. cap
201.20M
Avg. vol.
532.92K
Volume
650.90K
52-wk high
$5.55
52-wk low
$2.83
EPS
-$1.98
Beta
1.25
Shares outstanding
60.42M
No. of employees
141
Analyst outlook
Analyst Ratings
Based on 9 analysts giving stock ratings to VYGR in the past 3 months
Strong Buy
Buy
9
Hold
0
Sell
0
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for VYGR in the last 3 months.
Highest
Current $3.33
$25.00 (+650.75%)
Average
$15.14 (+354.65%)
Lowest
$8.00 (+140.24%)
News stories
From sources across the web
About Voyager Therapeutics Inc
CEO-
Employees141
Founded2013
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.47 / -$0.53
+12.03%beat
Revenue / Est. (USD)
2.59M / 8.79M
-70.49%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.20M
13.36M
15.34M
2.59M
Cost of goods sold
31.33M
35.87M
33.55M
24.60M
Cost of revenue
31.33M
35.87M
33.55M
24.60M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.50M
8.09M
8.22M
8.26M
Operating expense
10.50M
8.09M
8.22M
8.26M
Total operating expenses
41.82M
43.96M
41.77M
32.86M
Operating income
-36.62M
-30.59M
-26.43M
-30.27M
Other non operating income
427.00K
400.00K
404.00K
435.00K
EBT including unusual items
-33.37M
-27.81M
-27.42M
-27.92M
EBT excluding unusual items
-33.37M
-27.81M
-23.92M
-27.92M
Income tax expense
15.00K
83.00K
9.00K
14.00K
Effective tax rate
-0.04%
-0.30%
-0.03%
-0.05%
Other operating expenses
-
-
-
-
Net income
-33.38M
-27.89M
-27.43M
-27.94M
Net profit margin
-641.96%
-208.69%
-178.83%
-1,077.40%
Earnings per share
-0.57
-0.47
-0.47
-0.47
Interest and investment income
2.83M
2.38M
2.11M
1.91M
Interest expense
-
-
-
-
Net interest expenses
2.83M
2.38M
2.11M
1.91M
Depreciation and amortization charges
-
-
-
-
EBITDA
-35.56M
-29.66M
-25.38M
-29.34M
Gain or loss from assets sale
49.00K
-
62.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more